• Innovation Programmes
• Innovation facilities
• Innovation partners
• Innovation support
• Formulation expertise
• Clinical trial manufacturing

Ovelle quality

Ovelle is fully licensed by the Irish Medicines Board (IMB) to manufacture multi-dose liquid, semi-solid and solid pharmaceuticals operating under cGMP/GDP/GLP quality control systems.

This manufacturing licence is recognised in all countries of the European Union and by the World Health Organisation (WHO). Ovelle hold an IMP license to carry out Clinical Trial to support our customer’s strategies and product claims.